The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Anti-diabetic action of flower extract: Activation of PPAR-γ and identification of an active component
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“Activation of PPAR-g to improve the sensitivity of insulin receptors is the predominant mechanism for the anti-diabetic efficacy of PPAR-g agonists (Willson et al., 2000).”
BackgroundMedicinal plants of India with anti-diabetic potential
Grover, J. K., Yadav, S., & Vats, V. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00059-4 · Cited by 1,798
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1×
“In contrast, targeted disruption of GLUT-4 selectively in muscle causes a profound reduction in basal glucose transport and near absence of stimulation by insulin or contraction resulted, suggesting that GLUT-4-mediated glucose transport in muscle is essential to the maintenance of normal glucose homeostasis (Zisman e…”
BackgroundLeesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M., Patel, L., et al. (2002) · Biochemistry · doi:10.1021/bi0159581 · Cited by 616
Schubert, S. Y., Lansky, E. P., & Neeman, I. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00222-0 · Cited by 442
Anti-Inflammatory Activity of Gallic Acid
Kroes, B., van den Berg, A., Quarles van Ufford, H., van Dijk, H., & Labadie, R. (1992) · Planta Medica · doi:10.1055/s-2006-961535 · Cited by 422
Wu, Z., Xie, Y., Morrison, R. F., Bucher, N. L., & Farmer, S. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1244 · Cited by 357
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stumvoll, M., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 332
Aviram, M., Dornfeld, L., Kaplan, M., Coleman, R., Gaitini, D. E., Nitecki, S. S., Hofman, A., Rosenblat, M., Volkova, N., Presser, D., et al. (2002) · PubMed · Cited by 268
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.
Kasiske, B. L., O'Donnell, M. P., & Keane, W. F. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i110 · Cited by 263
Young, L. H., Renfu, Y., Russell, R., Hu, X., Caplan, M., Ren, J., Shulman, G. I., & Sinusas, A. J. (1997) · Circulation · doi:10.1161/01.cir.95.2.415 · Cited by 236
Glucose transport in the heart
Abel, E. (2004) · Frontiers in Bioscience · doi:10.2741/1216 · Cited by 233
Jafri, M. A., Aslam, M., Javed, K., & Singh, S. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00170-1 · Cited by 192
Experimental Models of Diabetes
(2018) · Routledge eBooks · doi:10.1201/9780203756386 · Cited by 188
Metabolic Abnormalities in the Diabetic Heart
Lopaschuk, G. D. (2002) · Heart Failure Reviews · doi:10.1023/a:1015328625394 · Cited by 184
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1415 · Cited by 172
Sidell, R. J., Cole, M. A., Draper, N. J., Desrois, M., Buckingham, R. E., & Clarke, K. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1110 · Cited by 165
Bishop‐Bailey, D., & Wray, J. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00003-0 · Cited by 151
Role of CD36, the Macrophage Class B Scavenger Receptor, in Atherosclerosis
NICHOLSON, A. C., Han, J., Febbraio, M., SILVERSTERIN, R. L., & Hajjar, D. P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03944.x · Cited by 136
Song, J., Knepper, M. A., Hu, X., Verbalis, J. G., & ECELBARGER, C. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058008 · Cited by 127
Thiazolidinediones: metabolic actions in vitro
Fürnsinn, C., & Waldhäusl, W. K. (2002) · Diabetologia · doi:10.1007/s00125-002-0899-1 · Cited by 101
Carley, A. N., Semeniuk, L. M., Shimoni, Y., Aasum, E., Larsen, T. S., Berger, J. P., & Severson, D. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2003 · Cited by 94
Das, A. K., Mandal, S. C., Banerjee, S. K., Sinha, S., Saha, B. P., & Pal, M. (2001) · Phytotherapy Research · doi:10.1002/ptr.740 · Cited by 89
PPAR agonists in the treatment of atherosclerosis
Francis, G. A., Annicotte, J.-S., & Auwerx, J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00014-6 · Cited by 88
Desrois, M., Sidell, R. J., Gauguier, D., Davey, C. L., Radda, G. K., & Clarke, K. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.014 · Cited by 77
Peroxisome proliferator activated
Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706481 · Cited by 74
Takagi, T., Naito, Y., Tomatsuri, N., Handa, O., Ichikawa, H., Yoshida, N., & Yoshikawa, T. (2002) · Redox Report · doi:10.1179/135100002125000802 · Cited by 66
Sung, C. K., She, H., Xiong, S., & Tsukamoto, H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2003 · Cited by 63
Davies, G. F., McFie, P. J., Khandelwal, R. L., & Roesler, W. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.72 · Cited by 62
Troglitazone suppresses cell growth of KU812 cells independently of PPARγ
Abe, A., Kiriyama, Y., Hirano, M., Miura, T., Kamiya, H., Harashima, H., & Tokumitsu, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01577-1 · Cited by 60
Li, L., Beauchamp, M.-C., & Renier, G. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00203-4 · Cited by 59
Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.3.e420 · Cited by 48
Novel insulin sensitizers: pharmacogenomic aspects
Otto, C., Lehrke, M., & Göke, B. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.99 · Cited by 33
Insulin Resistance and Endothelial Dysfunction in Atherosclerosis: Implications and Interventions
Dandona, P. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502321118829 · Cited by 19
Endothelium‐dependent contraction of rat thoracic aorta induced by gallic acid
Sanae, F., Miyaichi, Y., & Hayashi, H. (2003) · Phytotherapy Research · doi:10.1002/ptr.1255 · Cited by 15
Cited by
Lansky, E. P., & Newman, R. A. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.006 · Cited by 1,290
Pomegranate and its many functional components as related to human health: a review
Viuda‐Martos, M., Fernández‐López, J., & Pérez‐Álvarez, J. A. (2010) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2010.00131.x · Cited by 768
Tahraoui, A., El-Hilaly, J., Israili, Z. H., & Lyoussi, B. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.011 · Cited by 666
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
Wang, L., Waltenberger, B., Pferschy-Wenzig, E.-M., Blunder, M., Liu, X., Malainer, C., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.018 · Cited by 594
Ellagitannins, ellagic acid and vascular health
Larrosa, M., García-Conesa, M. T., Espín, J. C., & Tomás-Barberán, F. A. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.09.005 · Cited by 377
Metadata
- Authors
- HUANG, T., PENG, G., KOTA, B., LI, G., YAMAHARA, J., ROUFOGALIS, B., & LI, Y.
- Venue
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Published
- 2005-09-01
- Volume
- 207
- Issue
- 2
- Pages
- 160-169
- ISSN
- 0041-008X (ISSN-L)
- OpenAlex
- W2066894723
- Cited by
- 272
- References
- 38
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.